Needle Free Blood Drawing devices Market, Size, Share, Outlook and Growth Opportunities 2019-2026
Global Needle Free Blood Drawing devices Market is segmented By Technology Type (Venepunture, Touch based), By End Users (Hospitals, Research organizations, Diagnostic centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle Eas
(EMAILWIRE.COM, April 14, 2020 ) Market Overview
The Global Needle Free Blood Drawing devices Market is expected to grow at a CAGR during the forecasting period (2019-2026).
Needle-free blood drawing devices are used to draw the blood from the patients vein either by venepuncture or touch-enabled technology. In the case of venepuncture, the Intravenous Therapy (IV) needle is used to puncture the skin and then it is replaced with a plastic tube that becomes soft over some time. A product named PIVO a narrow-gauge tunnel is used to extract blood from veins with the help of existing IV tubes.
The touch-enabled systems use virtually invisible micro-needles and collect capillary blood by piercing the uppermost layer of the skin with the help of new microfluid extraction process.
Download free sample: https://www.datamintelligence.com/download-sample/needle-free-blood-drawing-devices-market
Market Drivers and Restraints
Increase in blood draws globally is one of the major factor having a positive impact on global needle-free blood drawing devices market, and is also expected to remain high over the forecast period.
In August 2017, Velano Vascular stated that 400 million blood draws occur annually in the U.S, as much as 70% of all our clinical decisions. Many of these are conducted in hospitals and patients receive almost three draws daily. This number gradually increases to 30% due to difficult venous access because of various conditions it includes (obesity, age, disease, etc.) which makes the process difficult.
One of the major factor hindering the global needle-free blood drawing devices market is its high economic expenditure and unexplored.
The cost involved in the process of blood drawing using needle-free blood drawing device is comparatively high when compared with traditional blood drawing.
Segmentation Analysis
The global needle-free blood drawing devices market is segmented on technology type which includes venepuncture and touch-based. Venepuncture involves piercing the vein, replacing it with a flexible mold and using it as a source to draw the blood. The touch-based system uses a tiny microneedle to suck the blood through the uppermost layer of the skin.
Touch technology-based devices are dominating the market in 2018, due to its availability and technological advancements. These are the great devices used multiple times on a single person whereas venepuncture based devices are replaced after every usage and it is expensive.
Geography Analysis
North America dominates the global needle-free blood drawing devices market in 2018, due to the increase in the adoption rate of devices in many health care centers across the region.
In September 2018, Intermountain healthcare in the U.S started implementing needle-free blood drawing for inpatients blood draws across its 22 hospitals.
In November 2018, Colorado Hospital started adopting needle-free, and in 6 weeks, the hospital has avoided about 4000 patient needle sticks.
In September 2018, University Hospitals Cleveland Medical Center in Ohio started adopting needle-free blood drawing device to reduce risks and anxiety from hospitalized patients.
Competitive Trends
Investments from major companies in the healthcare devices for research and development of needle-free blood drawing devices, Food and Drug Administration (FDA) approvals are driving the global needle-free blood drawing devices market.
In February 2018, Switzerland based Startup Loop Medical merged with Cerba Health care to develop unique needle-free blood drawing device.
In February 2017, FDA approved fast and virtually painless blood draw device from seventh sense Biosystems.
In March 2017, Velano Vascular gets the third FDA approval of needle-free blood draw device.
In 2016, Seventh Sense Biosystems is funded by Polaris partners, Siemens AG, Novartis International AG to develop a needle-free blood drawing device.
View full report: https://www.datamintelligence.com/research-report/needle-free-blood-drawing-devices-market
Enquiry before buying: https://www.datamintelligence.com/enquiry/needle-free-blood-drawing-devices-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
The Global Needle Free Blood Drawing devices Market is expected to grow at a CAGR during the forecasting period (2019-2026).
Needle-free blood drawing devices are used to draw the blood from the patients vein either by venepuncture or touch-enabled technology. In the case of venepuncture, the Intravenous Therapy (IV) needle is used to puncture the skin and then it is replaced with a plastic tube that becomes soft over some time. A product named PIVO a narrow-gauge tunnel is used to extract blood from veins with the help of existing IV tubes.
The touch-enabled systems use virtually invisible micro-needles and collect capillary blood by piercing the uppermost layer of the skin with the help of new microfluid extraction process.
Download free sample: https://www.datamintelligence.com/download-sample/needle-free-blood-drawing-devices-market
Market Drivers and Restraints
Increase in blood draws globally is one of the major factor having a positive impact on global needle-free blood drawing devices market, and is also expected to remain high over the forecast period.
In August 2017, Velano Vascular stated that 400 million blood draws occur annually in the U.S, as much as 70% of all our clinical decisions. Many of these are conducted in hospitals and patients receive almost three draws daily. This number gradually increases to 30% due to difficult venous access because of various conditions it includes (obesity, age, disease, etc.) which makes the process difficult.
One of the major factor hindering the global needle-free blood drawing devices market is its high economic expenditure and unexplored.
The cost involved in the process of blood drawing using needle-free blood drawing device is comparatively high when compared with traditional blood drawing.
Segmentation Analysis
The global needle-free blood drawing devices market is segmented on technology type which includes venepuncture and touch-based. Venepuncture involves piercing the vein, replacing it with a flexible mold and using it as a source to draw the blood. The touch-based system uses a tiny microneedle to suck the blood through the uppermost layer of the skin.
Touch technology-based devices are dominating the market in 2018, due to its availability and technological advancements. These are the great devices used multiple times on a single person whereas venepuncture based devices are replaced after every usage and it is expensive.
Geography Analysis
North America dominates the global needle-free blood drawing devices market in 2018, due to the increase in the adoption rate of devices in many health care centers across the region.
In September 2018, Intermountain healthcare in the U.S started implementing needle-free blood drawing for inpatients blood draws across its 22 hospitals.
In November 2018, Colorado Hospital started adopting needle-free, and in 6 weeks, the hospital has avoided about 4000 patient needle sticks.
In September 2018, University Hospitals Cleveland Medical Center in Ohio started adopting needle-free blood drawing device to reduce risks and anxiety from hospitalized patients.
Competitive Trends
Investments from major companies in the healthcare devices for research and development of needle-free blood drawing devices, Food and Drug Administration (FDA) approvals are driving the global needle-free blood drawing devices market.
In February 2018, Switzerland based Startup Loop Medical merged with Cerba Health care to develop unique needle-free blood drawing device.
In February 2017, FDA approved fast and virtually painless blood draw device from seventh sense Biosystems.
In March 2017, Velano Vascular gets the third FDA approval of needle-free blood draw device.
In 2016, Seventh Sense Biosystems is funded by Polaris partners, Siemens AG, Novartis International AG to develop a needle-free blood drawing device.
View full report: https://www.datamintelligence.com/research-report/needle-free-blood-drawing-devices-market
Enquiry before buying: https://www.datamintelligence.com/enquiry/needle-free-blood-drawing-devices-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results